NCT05255198

Brief Summary

Comparison between two minimally invasive approaches to the hip joint.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2016

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 30, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
Last Updated

February 24, 2022

Status Verified

February 1, 2022

Enrollment Period

3.1 years

First QC Date

August 30, 2021

Last Update Submit

February 15, 2022

Conditions

ArthroplastyClinical Outcome

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale

    Pain score

    one year after surgery

Study Arms (2)

Anterolateral approach

Procedure: Anterior versus lateral approach to hip joint

Direct anterior approach

Procedure: Anterior versus lateral approach to hip joint

Interventions

Anterior versus lateral approach to hip jointPROCEDURE
Anterolateral approachDirect anterior approach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consecutive patients, presenting with indication for bipolar hemiarthroplasty of the hip joint due to Garden III and IV fractures, who had given their written informed consent, were enrolled in the study. Exclusion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

August 30, 2021

First Posted

February 24, 2022

Study Start

May 1, 2016

Primary Completion

May 31, 2019

Study Completion

May 31, 2019

Last Updated

February 24, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share